Skip to main content
. 2021 Dec 8;135(3):333–340. doi: 10.1097/CM9.0000000000001876

Table 3.

Multivariate logistic regression analysis of factors for ALN pCR in the retrospective series.

Variable Coefficient SE Wald OR (95% CI) P value
Age∗ −0.391 0.205 3.647 0.677 (0.453–1.010) 0.056
Clinical T stage
 T2 −0.804 0.466 2.975 0.447 (0.179–1.116) 0.085
 T3 −0.598 0.470 1.622 0.550 (0.219–1.381) 0.203
 T4 −1.135 0.500 5.153 0.321 (0.121–0.856) 0.023
Pathological type Others† −0.292 0.515 0.322 0.747 (0.272–2.049) 0.570
Histologic grade
 II −0.180 0.629 0.082 1.106 (0.444–1.174) 0.775
 III 0.029 0.244 1.302 1.114 (0.658–1.710) 0.254
Primary tumor response CR −1.762 0.231 58.150 0.189 (0.123–0.292) <0.001
ER positive −0.635 0.284 4.991 0.530 (0.304–0.925) 0.025
PR positive −0.031 0.284 0.012 0.970 (0.555–1.694) 0.915
HER2 positive 0.331 0.231 2.047 1.392 (0.885–2.189) 0.153
∗

Continuous variables.

†

Others, invasive lobular carcinoma, invasive papillary carcinoma, mucinous carcinoma. CR: Complete response; CI: Confidence interval; ER: Estrogen receptor; HER2: Human epidermal growth factor receptor 2; OR: Odds ratio; Clinical T stage: Clinical tumor stage; PR: Progesterone receptor; pCR: Pathological complete response; SE: Standard error.